The rhythmic expression of PFKFB3, as well as CLOCK in cancerous cells was distinct from that in control cells, demonstrating the existence of circadian clock dysregulation that was closely associated with cancer development and progression (see below). The gene discussed is CLOCK; the disease is cancer.